Polymorphisms of the receptor for advanced glycation end-products and glyoxalase I in patients with renal cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Polymorphisms of the receptor for advanced glycation end-products and glyoxalase I in patients with renal cancer
Authors
Keywords
Receptor for advanced glycation end products, RAGE, Gloyxalase I, GLO1, Renal cell cancer
Journal
TUMOR BIOLOGY
Volume 36, Issue 3, Pages 2121-2126
Publisher
Springer Nature
Online
2014-11-21
DOI
10.1007/s13277-014-2821-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Somatic expression of ENRAGE is associated with obesity status among patients with clear cell renal cell carcinoma
- (2013) Jeanette E. Eckel-Passow et al. CARCINOGENESIS
- Polymorphisms of Receptor for Advanced Glycation end Products and Risk of Epithelial Ovarian Cancer in Chinese Patients
- (2013) Shuquan Zhang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Glyoxalase 1−419C>A Variant Is Associated with Oxidative Stress: Implications in Prostate Cancer Progression
- (2013) Cinzia Antognelli et al. PLoS One
- RAGE Genetic Polymorphisms Are Associated with Risk, Chemotherapy Response and Prognosis in Patients with Advanced NSCLC
- (2012) Xiang Wang et al. PLoS One
- Glyoxalase I polymorphism rs2736654 causing the Ala111Glu substitution modulates enzyme activity-implications for autism
- (2011) Madhabi Barua et al. Autism Research
- Receptor for advanced glycation end products (RAGE) partially mediates HMGB1-ERKs activation in clear cell renal cell carcinoma
- (2011) Liguo Lin et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- RAGE Gene Deletion Inhibits the Development and Progression of Ductal Neoplasia and Prolongs Survival in a Murine Model of Pancreatic Cancer
- (2011) Joseph DiNorcia et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Glyoxalase in tumourigenesis and multidrug resistance
- (2011) Paul J. Thornalley et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Soluble receptor for advanced glycation end-products (sRAGE) and polymorphisms of RAGE and glyoxalase I genes in patients with pancreas cancer
- (2010) Tomáš Krechler et al. CLINICAL BIOCHEMISTRY
- GLO1-A novel amplified gene in human cancer
- (2010) Thomas Santarius et al. GENES CHROMOSOMES & CANCER
- Contemporary Clinical Epidemiology of Renal Cell Carcinoma: Insight From a Population Based Case-Control Study
- (2010) David C. Miller et al. JOURNAL OF UROLOGY
- Genetic Predisposition to Advanced Glycation End Products Toxicity Is Related to Prognosis of Chronic Hemodialysis Patients
- (2010) Marta Kalousová et al. KIDNEY & BLOOD PRESSURE RESEARCH
- The -374A Allele of the RAGE Gene As a Potential Protective Factor for Vascular Complications in Type 2 Diabetes: A Meta-Analysis
- (2010) Weixin Lu et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
- Glyoxalase I Glu111Ala Polymorphism in Patients with Breast Cancer
- (2009) Alexandra Germanová et al. CANCER INVESTIGATION
- A419C (E111A) Polymorphism of the Glyoxalase I Gene and Vascular Complications in Chronic Hemodialysis Patients
- (2008) Marta Kalousová et al. Annals of the New York Academy of Sciences
- The −374T/A RAGE Polymorphism Protects Against Future Cardiac Events in Nondiabetic Patients with Coronary Artery Disease
- (2008) Colomba Falcone et al. ARCHIVES OF MEDICAL RESEARCH
- Gly82Ser Polymorphism of the Receptor for Advanced Glycation End Products Is Associated with an Increased Risk of Gastric Cancer in a Chinese Population
- (2008) H. Gu et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now